These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 94617)
1. Time- and dose-dependent changes in ejection fraction after anthracycline therapy. Narahara KA; Singer JW; Ritchie JL; Williams DL; Hamilton GW; Kennedy JW J Cardiovasc Pharmacol; 1979; 1(4):395-401. PubMed ID: 94617 [TBL] [Abstract][Full Text] [Related]
2. Time- and dose-dependent changes in ejection fraction determined by radionuclide angiography after anthracycline therapy. Singer JW; Narahara KA; Ritchie JL; Hamilton GW; Kennedy JW Cancer Treat Rep; 1978 Jun; 62(6):945-8. PubMed ID: 667873 [TBL] [Abstract][Full Text] [Related]
3. The cardiotoxicity of adriamycin and daunomycin in children. Gilladoga AC; Manuel C; Tan CT; Wollner N; Sternberg SS; Murphy ML Cancer; 1976 Feb; 37(2 Suppl):1070-8. PubMed ID: 1253124 [TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast. Speyer JL; Green MD; Dubin N; Blum RH; Wernz JC; Roses D; Sanger J; Muggia FM Am J Med; 1985 Apr; 78(4):555-63. PubMed ID: 3838618 [TBL] [Abstract][Full Text] [Related]
5. Radionuclide angiography for the evaluation of anthracycline therapy. Kennedy JW; Sorensen SG; Ritchie JL; Folland ED; Hamilton GW Cancer Treat Rep; 1978 Jun; 62(6):941-3. PubMed ID: 667872 [TBL] [Abstract][Full Text] [Related]
6. [Serial determination of anthracycline poisoning in children]. Stein JI; Langevin A; Benson LN; Souza MD; Wilson G; Chan H Wien Klin Wochenschr; 1989 Jan; 101(1):45-8. PubMed ID: 2913725 [TBL] [Abstract][Full Text] [Related]
7. [Long-term study of anthracycline-induced cardiomyopathy in children and adolescents]. Koch H; Schmitz L; Brockmeier K; Hartmann R; Bein G; Henze G Klin Padiatr; 1991; 203(4):262-7. PubMed ID: 1942932 [TBL] [Abstract][Full Text] [Related]
8. Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity. Adamson RH Cancer Chemother Rep; 1974; 58(3):293-4. PubMed ID: 4841712 [No Abstract] [Full Text] [Related]
9. Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography. Suzuki J; Yanagisawa A; Shigeyama T; Tsubota J; Yasumura T; Shimoyama K; Ishikawa K Angiology; 1999 Jan; 50(1):37-45. PubMed ID: 9924887 [TBL] [Abstract][Full Text] [Related]
10. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy]. Svojgrová M; Slechtová J; Hůla J Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075 [TBL] [Abstract][Full Text] [Related]
11. Non-invasive evaluation of anthracycline-induced cardiotoxicity in man. Lahtinen R; Uusitupa M; Kuikka J; Länsimies E Acta Med Scand; 1982; 212(4):201-6. PubMed ID: 7148515 [TBL] [Abstract][Full Text] [Related]
12. Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy. Santin JC; Deheinzelin D; Junior SP; Lopes LF; de Camargo B J Pediatr Hematol Oncol; 2007 Nov; 29(11):761-5. PubMed ID: 17984694 [TBL] [Abstract][Full Text] [Related]
13. Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy. Wiseman LR; Spencer CM Drugs; 1998 Sep; 56(3):385-403. PubMed ID: 9777314 [TBL] [Abstract][Full Text] [Related]
14. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance. Choi BW; Berger HJ; Schwartz PE; Alexander J; Wackers FJ; Gottschalk A; Zaret BL Am Heart J; 1983 Oct; 106(4 Pt 1):638-43. PubMed ID: 6613807 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin. Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095 [TBL] [Abstract][Full Text] [Related]
16. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer. Jain KK; Casper ES; Geller NL; Hakes TB; Kaufman RJ; Currie V; Schwartz W; Cassidy C; Petroni GR; Young CW J Clin Oncol; 1985 Jun; 3(6):818-26. PubMed ID: 3859587 [TBL] [Abstract][Full Text] [Related]
17. A prospective comparison of cardiac magnetic resonance imaging and radionuclide ventriculography in the assessment of cardiac function in patients treated with anthracycline-based chemotherapy. Sipola P; Vanninen E; Jantunen E; Nousiainen T; Kiviniemi M; Hartikainen J; Kuittinen T Nucl Med Commun; 2012 Jan; 33(1):51-9. PubMed ID: 22044862 [TBL] [Abstract][Full Text] [Related]
18. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy. Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730 [TBL] [Abstract][Full Text] [Related]
19. [Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy]. Okada Y; Horikawa K; Sano M Gan To Kagaku Ryoho; 1997 Mar; 24(5):585-9. PubMed ID: 9087292 [TBL] [Abstract][Full Text] [Related]
20. [Clinical usefulness of quantitative two-dimensional echocardiographic analysis of segmental kinesis of the left ventricle in monitoring of patients with neoplasms treated with anthracyclines]. Pisacane C; Iarussi D; Buono S; Gualtieri S; Coppolino P; Iacono A G Ital Cardiol; 1991 Dec; 21(12):1259-67. PubMed ID: 1818000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]